Financial overview

Abera Bioscience financial report data and keyfigures. History for income statement, balance sheet and cash flow.

Pre
Pre
Pre

Description

Abera Bioscience AB is a Swedish vaccine and biotechnology company that develops vaccines based on its own, according to the board, unique platform, BERA, which enables efficient development of vaccines based on bacterial OMV technology, outer membrane vesicles. The company, headquartered in Solna, Stockholm, was formed in 2012 and is branched into two business areas - platform technology and vaccine development. In addition, Abera participates in a number of collaborative projects in a number of different disease areas.

Biotechnology